OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Bianca Raffaelli, David García‐Azorín, Deirdre M. Boucherie, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Bianca Raffaelli, David García‐Azorín, Deirdre M. Boucherie, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Health equity, care access and quality in headache – part 2
Bianca Raffaelli, Eloísa Rubio‐Beltrán, Soo‐Jin Cho, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 28
Bianca Raffaelli, Eloísa Rubio‐Beltrán, Soo‐Jin Cho, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 28
Influence of metabolic state and body composition on the action of pharmacological treatment of migraine
Noor Bruijn, Romy van Lohuizen, Malgorzata Boron, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Noor Bruijn, Romy van Lohuizen, Malgorzata Boron, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Combining treatments for migraine prophylaxis: the state-of-the-art
Lanfranco Pellesi, David García‐Azorín, Eloísa Rubio‐Beltrán, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Lanfranco Pellesi, David García‐Azorín, Eloísa Rubio‐Beltrán, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Therapeutic barriers for headache management: issues facing the global north and global south in 2024
William Wells-Gatnik, Paolo Martelletti
Expert Review of Neurotherapeutics (2025), pp. 1-3
Closed Access
William Wells-Gatnik, Paolo Martelletti
Expert Review of Neurotherapeutics (2025), pp. 1-3
Closed Access
Framing and Management of Migraines in Women: An Expert Opinion on Challenges, Current Approaches, and Future Multidisciplinary Perspectives
Piero Barbanti, Rossella E. Nappi
Healthcare (2025) Vol. 13, Iss. 2, pp. 164-164
Open Access
Piero Barbanti, Rossella E. Nappi
Healthcare (2025) Vol. 13, Iss. 2, pp. 164-164
Open Access
Efficacy and tolerability of valproate versus topiramate in migraine prevention, a randomized controlled multi-center trial
Mohamed G. Zeinhom, Mohamed Fouad Elsayed Khalil, Tarek Youssif Omar Youssif, et al.
Journal of Clinical Neuroscience (2025) Vol. 135, pp. 111156-111156
Closed Access
Mohamed G. Zeinhom, Mohamed Fouad Elsayed Khalil, Tarek Youssif Omar Youssif, et al.
Journal of Clinical Neuroscience (2025) Vol. 135, pp. 111156-111156
Closed Access
Effectiveness of Topiramate Versus Acetazolamide in the Management of Idiopathic Intracranial Hypertension: ASystematic Review and Meta-Analysis
Abdullah Almaqhawi, Alia Alokley, Raghad Saad Alamri, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 450-450
Open Access
Abdullah Almaqhawi, Alia Alokley, Raghad Saad Alamri, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 450-450
Open Access
Quickest way to less headache days: an operational research model and its implementation for chronic migraine
Irene Lo, Pengfei Zhang
BMC Neurology (2025) Vol. 25, Iss. 1
Open Access
Irene Lo, Pengfei Zhang
BMC Neurology (2025) Vol. 25, Iss. 1
Open Access
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
David García‐Azorín, Cristina Martínez-Badillo, Javier Camiña Muñiz, et al.
Cephalalgia (2024) Vol. 44, Iss. 4
Closed Access | Times Cited: 2
David García‐Azorín, Cristina Martínez-Badillo, Javier Camiña Muñiz, et al.
Cephalalgia (2024) Vol. 44, Iss. 4
Closed Access | Times Cited: 2
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
Jan Versijpt, Christina Deligianni, Muizz Hussain, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Jan Versijpt, Christina Deligianni, Muizz Hussain, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Trends and prescribing patterns of antimigraine medicines in nine major cities in China from 2018 to 2022: a retrospective prescription analysis
Jing Huang, Xinwei Wang, Yiyi Jin, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Jing Huang, Xinwei Wang, Yiyi Jin, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Topiramate inhibits adjuvant-induced chronic orofacial inflammatory allodynia in the rat
Violetta Mohos, Máté Harmat, József Kun, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Violetta Mohos, Máté Harmat, József Kun, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Antiseizure medications
Mei T. Liu, Daniel Greer, Megan Maroney
Side effects of drugs annual (2024), pp. 69-111
Closed Access
Mei T. Liu, Daniel Greer, Megan Maroney
Side effects of drugs annual (2024), pp. 69-111
Closed Access
Anti-seizure medications for the management of migraine
Barbara L. Nye, Yonqqin Wu
Elsevier eBooks (2024), pp. 319-330
Closed Access
Barbara L. Nye, Yonqqin Wu
Elsevier eBooks (2024), pp. 319-330
Closed Access
